A Study of LY2181308 Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT00620321 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: LY2181308 sodium
DRUG: cytarabine
DRUG: idarubicin

Sponsor

Eli Lilly and Company